India's IOL Chemicals gains on hopes of exporting BP drug to Europe
** Shares of IOL Chemicals and Pharmaceuticals IOLC.NS
rise 4.2% to 413.64 rupees apiece
** IOLC on course to snap a six-session losing streak
** The company gets certificate of suitability from European
Directorate for the Quality of Medicines & Healthcare (EDQM) for
its blood pressure drug Valsartan
** Certification to help IOLC to export Valsartan in
European and other CEP accepting countries
** Shares of IOLC down 11% in 2024 so far
(Reporting by Bharath Rajeswaran in Bengaluru)
((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))
Recent news on IOL Chemicals and Pharmaceuticals
See all newsBrief: Iol Chemicals And Pharmaceuticals Says European Directorate For Quality Of Medicines & Healthcare Grants Certificate For Fenofibrate–Process II
Brief: IOL Chemicals And Pharmaceuticals June-Quarter Consol Profit 644 Million Rupees
Brief: IOL Chemicals and Pharmaceuticals Gets Approval From NMPA, China For Clopidogrel Bisulfate API
Brief: IOL Chemicals And Pharmaceuticals Reports Minor Fire Incident In Unit-9B Minoxidil Manufacturing Unit On June 9
Brief: IOL Chemicals And Pharmaceuticals March-Quarter Consol Profit 531.6 Million Rupees